A large number of broker notes have hit the wires this week, leading to many popular shares being declared buys and sells.
Three shares that are in favour with brokers and have been given a buy rating are listed below. Here’s why they are bullish on them:
Helloworld Travel Ltd (ASX: HLO)
According to a note out of Ord Minnett, its analysts have retained their buy rating and $6.14 price target on this integrated travel company’s shares. The broker believes that the recent share price decline caused by a political scandal is a buying opportunity for investors. It suspects that the market is concerned that Helloworld could lose its Federal Government contracts, but notes that any potential loss would only have a small impact on its earnings. I agree with Ord Minnett on Helloworld and feel it would be a great option for investors. Especially considering its shares are changing hands at under 14x estimated earnings and offer a 4% fully franked forward dividend.
ResMed Inc. (ASX: RMD)
A note out of Deutsche Bank reveals that its analysts have upgraded this sleep treatment-focused medical device company’s shares to a buy rating with a US$125.00 (~A$17.53) price target. According to the note, although the broker felt ResMed’s second quarter result was underwhelming, it believes this was due to the company’s ROTW segment cycling a particularly strong prior period. Deutsche believes investors ought to look beyond this and to the large growth opportunity the company has from increasing awareness and the further penetration of the sleep apnoea market. I agree with Deutsche Bank on ResMed and believe it would be a great investment.
Wesfarmers Ltd (ASX: WES)
Analysts at Morgans have retained their add rating and $36.50 price target on this conglomerate’s shares after the Bunnings Investor Day event. According to the note, the broker appears pleased with the growth opportunities that the company is considering for Bunnings. These include the expansion of several categories and the launch of a fully transactional website. In addition to this, the broker appears pleased that the company’s balance sheet gives it the flexibility to take advantage of opportunities when necessary. I think Morgans is spot on and agree that Wesfarmers is a buy.
These 3 stocks could be the next big movers in 2020
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.
*Returns as of 6/8/2020
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Wesfarmers Limited. The Motley Fool Australia owns shares of Helloworld Limited. The Motley Fool Australia has recommended ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
- Why I would buy CBA (ASX:CBA) and this beaten down ASX share – September 22, 2020 4:31pm
- 3 quality small cap ASX shares with very strong growth potential – September 22, 2020 4:30pm
- Buy these ASX dividend shares to beat low interest rates – September 22, 2020 4:00pm